Search Results

There are 1133 results for: content related to: Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells

  1. You have full text access to this OnlineOpen article
    GRP78/Dna K Is a Target for Nexavar/Stivarga/Votrient in the Treatment of Human Malignancies, Viral Infections and Bacterial Diseases

    Journal of Cellular Physiology

    Volume 230, Issue 10, October 2015, Pages: 2552–2578, Jane L. Roberts, Mehrad Tavallai, Aida Nourbakhsh, Abigail Fidanza, Tanya Cruz-Luna, Elizabeth Smith, Paul Siembida, Pascale Plamondon, Kelly A. Cycon, Christopher D. Doern, Laurence Booth and Paul Dent

    Article first published online : 23 JUN 2015, DOI: 10.1002/jcp.25014

  2. Effects of Antitumor Drug Sorafenib on Chick Embryo Development

    The Anatomical Record

    Volume 298, Issue 7, July 2015, Pages: 1271–1281, Yi-Sen Cheng, Xiao-Yu Wang, Guang Wang, Yan Li, Yue-Lei Chen, Man-li Chuai, Kenneth Ka Ho Lee, Xiao-Yan Ding and Xue-song Yang

    Article first published online : 17 APR 2015, DOI: 10.1002/ar.23155

  3. You have free access to this content
    Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen–positive myeloid cell infiltration in mice

    Hepatology

    Volume 59, Issue 4, April 2014, Pages: 1435–1447, Yunching Chen, Yuhui Huang, Thomas Reiberger, Annique M. Duyverman, Peigen Huang, Rekha Samuel, Lotte Hiddingh, Sylvie Roberge, Christina Koppel, Gregory Y. Lauwers, Andrew X. Zhu, Rakesh K. Jain and Dan G. Duda

    Article first published online : 18 FEB 2014, DOI: 10.1002/hep.26790

  4. You have free access to this content
    Discovery of novel src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma

    Hepatology

    Volume 59, Issue 1, January 2014, Pages: 190–201, Wei-Tien Tai, Chung-Wai Shiau, Pei-Jer Chen, Pei-Yi Chu, Hsiang-Po Huang, Chun-Yu Liu, Jui-Wen Huang and Kuen-Feng Chen

    Article first published online : 9 DEC 2013, DOI: 10.1002/hep.26640

  5. You have free access to this content
    Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2

    Hepatology

    Volume 50, Issue 6, December 2009, Pages: 1861–1870, Boris R. A. Blechacz, Rory L. Smoot, Steven F. Bronk, Nathan W. Werneburg, Alphonse E. Sirica and Gregory J. Gores

    Article first published online : 5 AUG 2009, DOI: 10.1002/hep.23214

  6. You have free access to this content
    Effect of sorafenib on murine liver regeneration

    Hepatology

    Volume 53, Issue 2, February 2011, Pages: 577–586, Caroline Hora, Pamela Romanque and Jean-François F. Dufour

    Article first published online : 4 JAN 2011, DOI: 10.1002/hep.24037

  7. You have full text access to this Open Access content
    Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma

    Journal of Cellular and Molecular Medicine

    Volume 13, Issue 8b, August 2009, Pages: 2673–2683, Hung Huynh, Van Chanh Ngo, Heng Nung Koong, Donald Poon, Su Pin Choo, Choon Hua Thng, Pierce Chow, Hock Soo Ong, Alexander Chung and Khee Chee Soo

    Article first published online : 11 FEB 2009, DOI: 10.1111/j.1582-4934.2009.00692.x

  8. You have free access to this content
    Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis

    Hepatology

    Volume 54, Issue 2, August 2011, Pages: 573–585, Dominique Thabut, Chittaranjan Routray, Gwen Lomberk, Uday Shergill, Kevin Glaser, Robert Huebert, Leena Patel, Tetyana Masyuk, Boris Blechacz, Andrew Vercnocke, Erik Ritman, Richard Ehman, Raul Urrutia and Vijay Shah

    Article first published online : 26 JUN 2011, DOI: 10.1002/hep.24427

  9. You have full text access to this OnlineOpen article
    Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation

    International Journal of Cancer

    Volume 136, Issue 6, 15 March 2015, Pages: 1434–1444, Floris H. Groenendijk, Wouter W. Mellema, Eline van der Burg, Eva Schut, Michael Hauptmann, Hugo M. Horlings, Stefan M. Willems, Michel M. van den Heuvel, Jos Jonkers, Egbert F. Smit and René Bernards

    Article first published online : 8 AUG 2014, DOI: 10.1002/ijc.29113

  10. You have free access to this content
    ABT-263 enhances sorafenib-induced apoptosis associated with Akt activity and the expression of Bax and p21(CIP1/WAF1) in human cancer cells

    British Journal of Pharmacology

    Volume 171, Issue 13, July 2014, Pages: 3182–3195, Jingru Li, Yicheng Chen, Jiali Wan, Xin Liu, Chunrong Yu and Wenhua Li

    Article first published online : 10 JUN 2014, DOI: 10.1111/bph.12659

  11. You have free access to this content
    Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats

    Hepatology

    Volume 49, Issue 4, April 2009, Pages: 1245–1256, Marc Mejias, Ester Garcia-Pras, Carolina Tiani, Rosa Miquel, Jaime Bosch and Mercedes Fernandez

    Article first published online : 25 NOV 2008, DOI: 10.1002/hep.22758

  12. You have free access to this content
    Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib

    Hepatology

    Volume 56, Issue 6, December 2012, Pages: 2363–2374, Carlo Spirli, Carola M. Morell, Luigi Locatelli, Stefano Okolicsanyi, Cecilia Ferrero, Amy K. Kim, Luca Fabris, Romina Fiorotto and Mario Strazzabosco

    Article first published online : 27 AUG 2012, DOI: 10.1002/hep.25872

  13. You have free access to this content
    Sorafenib delays recurrence and metastasis after liver transplantation in a rat model of hepatocellular carcinoma with high expression of phosphorylated extracellular signal-regulated kinase

    Liver Transplantation

    Volume 19, Issue 5, May 2013, Pages: 507–520, Jun Yan, Changjun Tan, Fangming Gu, Jiahao Jiang, Min Xu, Xiuzhen Huang, Zhi Dai, Zheng Wang, Jia Fan and Jian Zhou

    Article first published online : 25 APR 2013, DOI: 10.1002/lt.23619

  14. You have free access to this content
    Sorafenib/Regorafenib and Lapatinib Interact to kill CNS Tumor Cells

    Journal of Cellular Physiology

    Volume 230, Issue 1, January 2015, Pages: 131–139, Hossein A. Hamed, Seyedmehrad Tavallai, Steven Grant, Andrew Poklepovic and Paul Dent

    Article first published online : 29 SEP 2014, DOI: 10.1002/jcp.24689

  15. You have full text access to this OnlineOpen article
    A multifactorial anti-cachectic approach for cancer cachexia in a rat model undergoing chemotherapy

    Journal of Cachexia, Sarcopenia and Muscle

    Míriam Toledo, Fabio Penna, Francesc Oliva, Melania Luque, Angelica Betancourt, Enrica Marmonti, Francisco J. López-Soriano, Josep M. Argilés and Sílvia Busquets

    Article first published online : 14 MAY 2015, DOI: 10.1002/jcsm.12035

  16. Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growth

    Pediatric Blood & Cancer

    Volume 59, Issue 4, October 2012, Pages: 642–647, Nisha C. Kakodkar, Radhika R. Peddinti, Yufeng Tian, Lisa J. Guerrero, Alexandre Chlenski, Qiwei Yang, Helen R. Salwen, Michael L. Maitland and Susan L. Cohn

    Article first published online : 6 DEC 2011, DOI: 10.1002/pbc.24004

  17. Sorafenib and HDAC inhibitors synergize with TRAIL to kill tumor cells

    Journal of Cellular Physiology

    Volume 228, Issue 10, October 2013, Pages: 1996–2005, Hossein A. Hamed, Yukihiro Yamaguchi, Paul B. Fisher, Steven Grant and Paul Dent

    Article first published online : 20 JUN 2013, DOI: 10.1002/jcp.24362

  18. You have free access to this content
    Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity

    International Journal of Cancer

    Volume 134, Issue 2, 15 January 2014, Pages: 319–331, Mei-Ling Chen, Bo-Shiun Yan, Wan-Chih Lu, Mei-Huei Chen, Sung-Liang Yu, Pan-Chyr Yang and Ann-Lii Cheng

    Article first published online : 30 JUL 2013, DOI: 10.1002/ijc.28362

  19. You have free access to this content
    Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib – the role of extracellular signal-regulated kinase counteraction

    FEBS Journal

    Volume 278, Issue 18, September 2011, Pages: 3494–3507, Irena Manov, Yulia Pollak, Rinata Broneshter and Theodore C. Iancu

    Article first published online : 5 SEP 2011, DOI: 10.1111/j.1742-4658.2011.08271.x

  20. Sorafenib induces endometrial carcinoma apoptosis by inhibiting Elk-1-dependent Mcl-1 transcription and inducing Akt/GSK3β-dependent protein degradation

    Journal of Cellular Biochemistry

    Volume 114, Issue 8, August 2013, Pages: 1819–1831, Nian-Kang Sun, Shang-Lang Huang, Ting-Chang Chang and Chuck C.-K. Chao

    Article first published online : 11 JUN 2013, DOI: 10.1002/jcb.24530